Table 1.
Patients reaching OPU | Patients with cancelled cycles | p | |
---|---|---|---|
Age (years) | 38.1 ± 3.5 | 38.1 ± 3.1 | ns |
AMH (ng/ml) | 0.3 ± 0.2 | 0.2 ± 0.2 | <0.0001 |
BMI (kg/m2) | 22.9 ± 3.4 | 22.5 ± 3.6 | ns |
AFC | 6.5 ± 3.2 | 4.3 ± 2.2 | <0.0001 |
FSH (IU/l) | 10.5 ± 4.3 | 13.3 ± 5.6 | <0.0001 |
Ovarian endometriosisa | 73 (19.1 %) | 36 (55.4 %) | <0.001 |
COS protocol | |||
GnRH agonist “long” | 194 (50.7 %) | 20 (30.8 %) | ns |
GnRH antagonist | 189 (49.3 %) | 45 (69.2 %) | |
Medications | |||
Recombinant Gn | 132 (34.5 %) | 14 (20.3 %) | ns |
hMG | 251 (65.5 %) | 51 (79.7 %) |
Data are expressed as mean ± SD or percentage
aPatients with an endometrioma <4 cm during IVF or previously operated to remove an endometrioma